Blog
XOMA Revenue Jumps 39% in Fiscal Q2
XOMA (NASDAQ:XOMA), a biotechnology royalty aggregator, reported second quarter results on August 13, 2025, for the period ending June 30. The company’s revenue (GAAP) reached $13.1 million for Q2
D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock?
Quantum computing stocks are absolutely sizzling right now. Over the last year, two companies that have emerged as frontrunners in the quantum computing revolution are IonQ (NYSE: IONQ) and D-Wave
Madison Square Garden Beats Q4 Revenue
Madison Square Garden Entertainment (NYSE:MSGE), the owner and operator of iconic live entertainment venues, released its Q4 FY2025 earnings on August 13, 2025. The main headlines from the release
Could Ethereum Hit $5,000 Before 2026?
Great investing often comes down to asking simple questions at the right time. Today's biggest questions about Ethereum (CRYPTO: ETH) are whether it can surpass the $5,000 level and, more
Adaptimmune Sales Jump 59 Percent
Adaptimmune Therapeutics Plc (NASDAQ:ADAP), a biotechnology company specializing in engineered T-cell therapies for cancer, released its second-quarter earnings on August 13, 2025, covering results
Sagimet Biosciences Tops Q2 EPS Forecast
Sagimet Biosciences (NASDAQ:SGMT), a clinical-stage biotechnology developer focused on fatty acid synthase (FASN) inhibitors, delivered its second-quarter results on August 13, 2025. The most
Mesa Air Posts Profit in Fiscal Q3
Mesa Air Group (NASDAQ:MESA), a regional airline operating primarily under capacity purchase agreements for major U.S. carriers, released its third-quarter fiscal 2025 results on August 13, 2025
Local Bounti Posts 28% Sales Gain in Q2
Local Bounti (NYSE:LOCL), a controlled environment agriculture company specializing in sustainably grown produce, reported its second quarter 2025 earnings on August 13, 2025. The most significant
Prediction: This Artificial Intelligence (AI) Stock Will Outperform Nvidia Through 2030
If you look back at the past couple of years, there's arguably no stock that has received as much attention as Nvidia (NASDAQ: NVDA). The current artificial intelligence (AI) boom has propelled
Is This Underrated Artificial Intelligence (AI) Stock the Next Big Winner?
Investors are getting to know artificial intelligence (AI) infrastructure company Nebius Group (NASDAQ: NBIS). It's been somewhat under the radar until Nebius recently released its second-quarter
Sbc Medical Group Posts Weak Fiscal Q2
Sbc Medical Group (NASDAQ:SBC), a provider of cosmetic and medical services with a broad franchise and technology platform, released its earnings for the second quarter of fiscal 2025 on August 13
The Smartest Energy Stocks to Buy With $1,000 Right Now
Energy of all kinds is vital to modern life. But the world doesn't sit still, either, and the types of energy that the world demands are starting to change. Although an all-of-the-above strategy is
Mersana Misses Fiscal Q2 Revenue Target
Mersana Therapeutics (NASDAQ:MRSN), a clinical-stage biotech specializing in antibody-drug conjugates (ADCs) for cancer, reported its second quarter results on August 13, 2025. The company’s update
Tourmaline Bio Reports Loss as R&D Rises
Tourmaline Bio (NASDAQ:TRML), a clinical-stage biotechnology company focusing on treatments for inflammatory diseases, published its earnings for the second quarter on August 13, 2025. The most
Sanara MedTech Sales Jump 28 Percent
Sanara MedTech (NASDAQ:SMTI), a developer of surgical wound care products and value-based care technology, reported its Q2 FY2025 earnings on August 13, 2025. The report showed the company’s GAAP
PDSB Loss Improves as Costs Drop
PDS Biotechnology (NASDAQ:PDSB), a clinical-stage immunotherapy company focused on innovative oncology and infectious disease solutions, released its second quarter results on August 13, 2025, for
This Legacy Stock Is Back, Poised for a Major Rebound
Retail stocks have been through a few tough years. The SPDR S&P Retail ETF (NYSEMKT: XRT) posted a total return of 12% over the last year, far behind the S&P 500 (SNPINDEX: ^GSPC) index's 19%
Will Starlink SPAC or IPO in 2025?
For years, many investors have been waiting to get a piece of SpaceX, the massive space exploration company led by Tesla (NASDAQ: TSLA) CEO Elon Musk. According to most lists, SpaceX is the most
Aura Biosciences Posts Q2 Cash Surge
Aura Biosciences (NASDAQ:AURA), a biotechnology company focused on developing virus-like drug conjugates for cancer with an emphasis on ocular oncology, reported its second quarter 2025 financial
Performance Food Sales Jump 12 Percent
Performance Food Group (NYSE:PFGC), a leading foodservice distributor serving restaurants, convenience stores, vending, and more, reported financial results for Q4 FY2025 on August 13, 2025. The
Crown Crafts Sales Drop 4.5 Percent
Crown Crafts (NASDAQ:CRWS), a developer and distributor of infant and juvenile consumer products, released its earnings for the fiscal first quarter 2026 on August 13, 2025. Crown Crafts reported
Instil Bio Posts Wider Loss in Q2
Instil Bio (NASDAQ:TIL), a clinical-stage biotechnology company focused on developing immunotherapies for cancer, released its second quarter 2025 earnings on August 13, 2025. The report highlighted
How Much Should Retirees Have Invested by Age 67?
Everyone dreams of a comfortable retirement, but it's a reality too few realize. The median U.S. household aged 65 to 74 has just $200,000 saved for retirement.
Using the popular 4% rule, a retiree
Palantir Technologies Stock: Will It Hit a $500 Billion Valuation This Year?
Unstoppable -- that's the one word I would use to describe Palantir Technologies (NASDAQ: PLTR) stock. There seems to be no way to stop its ascent. Even though its valuation may be telling you the
Perspective Therapeutics Reports Q2 Loss
Perspective Therapeutics (NYSEMKT:CATX), a clinical-stage company focused on targeted radiopharmaceutical cancer therapies, reported results for Q2 2025 on August 13, 2025. The company posted GAAP